Share on LinkedInShare on LinkedIn

ARTICLE · 17 SEPTEMBER 2026

Peptides In Canada: Regulatory Reality Is Catching Up With The Hype

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

Health Canada's recent enforcement action against unauthorized injectable peptides signals a regulatory shift that wellness companies cannot afford to ignore. While peptides dominate influencer marketing and online wellness spaces, their legal status in Canada depends on factors far more complex than social media trends suggest. Understanding how route of administration, therapeutic claims, and market authorization intersect is now critical for compliance.

CanadaConsumer Protection

Peptides are having a moment in the wellness space, driven in part by influencer marketing. But in Canada, their regulatory status is far less trendy than the online hype suggests.

How peptides are (and are not) regulated in Canada

Under the Food and Drugs Act, Health Canada does not regulate peptides as a single category. Instead, classification depends on factors such as intended use, route of administration and claims. In practice, most peptides promoted for performance, anti-aging or therapeutic effects are regulated as drugs.

A small number of peptide-based products are fully authorized pharmaceuticals. These include well-known therapies such as insulin analogues and GLP-1 receptor agonists like semaglutide. These products have undergone extensive clinical study and regulatory review, hold the required Canadian market authorization, and are available by prescription.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from